Green tea polyphenols and 1-α-OH-vitamin D 3 attenuate chronic inflammation-induced myocardial fibrosis in female rats

Journal of Medicinal Food

Volumn 15, Issue 3, 2012, Pages 269-277

  Shen, Chwan Li ^a,b   Samathanam, Christina ^c   Graham, Suzanne ^a   Dagda, Raul Y ^a   Chyu, Ming Chien ^d   Dunn, Dale M ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER SCHOOL OF MEDICINE   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d Department of Electrical and Computer Engineering   (United States)

Author keywords

Alphacalcidol; Inflammation; Innate immune response; Tea

Indexed keywords

ALFACALCIDOL; CHOLESTEROL; CYCLOOXYGENASE 2; GREEN TEA POLYPHENOL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN; LIPOPOLYSACCHARIDE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PLACEBO; POLYPHENOL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHRONIC INFLAMMATION; CONTROLLED STUDY; CORONARY BLOOD VESSEL; DRUG POTENTIATION; EOSINOPHIL COUNT; ERYTHROCYTE COUNT; FEMALE; HEART MUSCLE FIBROSIS; HEMATOCRIT; HISTOPATHOLOGY; INNATE IMMUNITY; LEUKOCYTE COUNT; LIPID ANALYSIS; NEUTROPHIL COUNT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN; TEA;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CORONARY VESSELS; CYCLOOXYGENASE 2; DIETARY SUPPLEMENTS; ENDOMYOCARDIAL FIBROSIS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROXYCHOLECALCIFEROLS; IMMUNITY, INNATE; LEUKOCYTOSIS; MYOCARDIUM; PHYTOTHERAPY; POLYPHENOLS; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; RNA, MESSENGER; SPLEEN; TEA;

RATTUS;

EID: 84857564379     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2011.0163     Document Type: Article

References (44)

1. Piro M, Giubilato G, Pinnelli M, Giordano Sciacca P, Biasucci LM: Endothelium and inflammation. Panminerva Med 2005;47: 75-80. (Pubitemid 41634928)
2. Yan ZQ, Hansson GK: Innate immunity, macrophage activation, and atherosclerosis. Immunol Rev 2007;219:187-203. (Pubitemid 47390007)
3. Miller AM, McInnes IB: Cytokines as therapeutic targets to reduce cardiovascular risk in chronic inflammation. Curr Pharm Des 2011;17:1-8.
4. Tang J, Raines EW: Are suppressors of cytokine signaling proteins recently identified in atherosclerosis possible therapeutic targets? Trends Cardiovasc Med 2005;15:243-249. (Pubitemid 41437906)
5. Lin CC, Lin WN, Wang WJ, Sun CC, Tung WH, Wang HH, Yang CM: Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-kappaB. Cardiovasc Res 2009;82: 522-531.
6. Ringe JD, Schacht E: Prevention and therapy of osteoporosis: the roles of plain vitamin D and alfacalcido. Rheumatol Int 2004;24: 189-197. (Pubitemid 39062487)
7. Ringe JD, Faber H, Fahramand P: Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis. J Rheumatol Suppl 2005;76:33-40. (Pubitemid 41324842)
8. Teng M, Wolf M, Lowrie E, Ofshun N, Lazarus JM, Thadhani R: Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003;349:446-456. (Pubitemid 36910023)
9. Shoji T, Shinohara K, Kimoto E, Emoto M, Tahara H, Koyama H, Inaba M, Fukumoto S, Ishimura E, Miki T, Tabata T, Nishizawa Y: Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population. Nephrol Dial Transplant 2004;19:179-184. (Pubitemid 38072630)
10. Wolf M, Betancourt J, Chang Y, Shah A, Teng M, Tamez H, Gutierrez O, Camargo CA Jr, Melamed M, Norris K, Stampfer MJ, Powe NR, Thadhani R: Impact of activated vitamin D and race on survival among hemodialysis patients. J Am Soc Nephrol 2008;19:1379-1388.
11. Giulietti A, van Etten E, Overbergh L, Stoffels K, Bouillon R, Mathieu C: Monocytes from type 2 diabetic patients have a proinflammatory profile. 1,25-Dihydroxyvitamin D3 works as antiinflammatory. Diabetes Res Clin Pract 2007;77:47-57. (Pubitemid 46590467)
12. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I: Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan. JAMA 2006;296:1255-1265. (Pubitemid 44394897)
13. Stangl V, Dreger H, Stangl K, Lorenz M: Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res 2007;73:348-358. (Pubitemid 44937692)
14. Sueoka N, Suganuma M, Sueoka E, Okabe S, Matsuyama S, Imai K, Nakachi K, Fujiki H: A new function of green tea: prevention of lifestyle-related diseases. Ann NY Acad Sci 2001;928:274-280. (Pubitemid 32386088)
15. Moore RJ, Jackson KG, Minihane AM: Green tea (Camellia sinensis) catechins and vascular function. Br J Nutr 2009;102: 1790-1802.
16. Mineharu Y, Koizumi A, Wada Y, Iso H, Watanabe Y, Date C, Yamamoto A, Kikuchi S, Inaba Y, Toyoshima H, Kondo T, Tamakoshi A; JACC Study Group: Coffee, green tea, black tea and oolong tea consumption and risk of mortality from cardiovascular disease in Japanese men and women. J Epidemiol Community Health 2011;65:230-240.
17. Shen CL, Samathanam C, Tatum OL, Graham S, Tubb C, Cao JJ, Dunn DM, Wang JS: Green tea polyphenols avert chronic inflammation-induced myocardial fibrosis of female rats. Inflamm Res 2011;60:665-672
18. Smith BJ, Lerner MR, Bu SY, Lucas EA, Hanas JS, Lightfoot SA, Postier RG, Bronze MS, Brackett DJ: Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone 2006;38:378-386. (Pubitemid 43255432)
19. Smith BJ, Lightfoot SA, Lerner MR, Denson KD, Morgan DL, Hanas JS, Bronze MS, Postier RG, Brackett DJ: Induction of cardiovascular pathology in a novel model of low-grade chronic inflammation. Cardiovasc Pathol 2009;18:1-10.
20. Shen CL, Yeh JK, Samathanam C, Cao JJ, Stoecker BJ, Dagda RY, Chyu MC, Dunn DM, Wang JS: Green tea polyphenols attenuate deterioration of bone microarchitecture in female rats with systemic chronic inflammation. Osteoporos Int 2011;22: 327-337.
21. Shen CL, Yeh JK, Cao JJ, Tatum OL, Dagda RY, Wang JS: Green tea polyphenols mitigate bone loss of female rats in a chronic inflammation-induced bone loss model. J Nutr Biochem 2010;21:968-974.
22. Wang JS, Luo H, Wang P, Tang L, Yu J, Huang T, Cox S, Gao W: Validation of green tea polyphenol biomarkers in a phase II human intervention trial. Food Chem Toxicol 2008;46: 232-240. (Pubitemid 350235769)
23. Shen CL, Wang P, Guerrieri J, Yeh JK, Wang JS: Protective effect of green tea polyphenols on bone loss in middle-aged female rats. Osteoporos Int 2008;19:979-990.
24. Sánchez-Lemus E, Benicky J, Pavel J, Larrayoz IM, Zhou J, Baliova M, Nishioku T, Saavedra JM: Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen. Am J Physiol Regul Integr Comp Physiol 2009;296:R1376-R1384.
25. Valen G, Yan ZQ, Hansson GK: Nuclear factor kappa-B and the heart. J Am Coll Cardiol 2001;38:307-314. (Pubitemid 32721754)
26. Zidar N, Dolenc-Strazar Z, Jeruc J, Jerse M, Balazic J, Gartner U: Expression of cyclooxygenase-1 and cyclooxygenase-2 in the normal human heart and in myocardial infarction. Cardiovasc Pathol 2007;16:300-304. (Pubitemid 47381500)
27. Krishnan AV, Moreno J, Nonn L, Swami S, Peehl DM, Feldman D: Calcitriol as a chemopreventive and therapeutic agent in prostate cancer: role of anti-inflammatory activity. J Bone Miner Res 2007;22(Suppl 2):V74-V80. (Pubitemid 351304654)
28. Tipoe GL, Leung TM, Liong EC, Lau TY, Fung ML, Nanji AA: Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice. Toxicology 2010;273:45-52.
29. Koeberle A, Bauer J, Verhoff M, Hoffmann M, Northoff H, Werz O: Green tea epigallocatechin-3-gallate inhibits microsomal prostaglandin E2 synthase-1. Biochem Biophys Res Commun 2009;388:350-354.
30. Gokulakrisnan A, Jayachandran Dare B, Thirunavukkarasu C: Attenuation of the cardiac inflammatory changes and lipid anomalies by (-)-epigallocatechin- gallate in cigarette smokeexposed rats. Mol Cell Biochem 2011;354:1-10.
31. Ahmed S, Rahman A, Hasnain A, Lalonde M, Goldberg VM, Haqqi TM: Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Biol Med 2002;33:1097-1105.
32. Albelda SM, Oliver PD, Romer LH, Buck CA: EndoCAM: a novel endothelial cell-cell adhesion molecule. J Cell Biol 1990;110:1227-1237.
33. McMahon L, Schwartz K, Yilmaz O, Brown E, Ryan LK, Diamond G: Vitamin D-mediated induction of innate immunity in gingival epithelial cells. Infect Immun 2011;79:2250-2256.
34. Bartley J: Vitamin D: emerging roles in infection and immunity. Expert Rev Anti Infect Ther 2010;8:1359-1369.
35. Ramesh E, Geraldine P, Thomas PA: Regulatory effect of epigallocatechin gallate on the expression of C-reactive protein and other inflammation markers in an experimental model of atherosclerosis. Chem Biol Interact 2010;183:125-132.
36. Dona M, Dell'Aica I, Calabrese F, Benelli R, Morini M, Albini A, Garbisa S: Neutrophil restraint by green tea: inhibition of inflammation associated angiogenesis and pulmonary fibrosis. J Immunol 2003;170:4335-4341. (Pubitemid 36428203)
37. Ludwig A, Lorenz M, Grimbo N, Steinle F, Meiners S, Bartsch C, Stangl K, Baumann G, Stangl V: The tea flavonoid epigallocatechin-3-gallate reduces cytokine-induced VCAM-1 expression and monocyte adhesion to endothelial cells. Biochem Biophys Res Commun 2004;316:659-665. (Pubitemid 38368003)
38. Hofbauer R, Frass M, Gmeiner B, Handler S, Speiser W, Kapiotis S: The green tea extract epigallocatechin gallate is able to reduce neutrophil transmigration through monolayers of endothelial cells. Wien Klin Wochenschr 1999;111:278-282. (Pubitemid 29200425)
39. Lowe GD, Rumley A, Whincup PH, Danesh J: Hemostatic and rheological variables and risk of cardiovascular disease. Semin Vasc Med 2002;2:429-439.
40. Liese AM, Siddiqi MQ, Siegel JH, Denny T, Spolarics Z: Augmented TNF-alpha and IL-10 production by primed human monocytes following interaction with oxidatively modified autologous erythrocytes. J Leukoc Biol 2001;70:289-296. (Pubitemid 32751521)
41. Starzyk D, Korbut R, Grygelwski RJ: The role of nitric oxide in regulation of deformability of red blood cells in acute phase of endotoxaemia in rats. J Physiol Pharmacol 1997;48:731-735. (Pubitemid 28055599)
42. Sih TR, Morris JG, Hickman MA: Chronic ingestion of high concentrations of cholecalciferol in cats. Am J Vet Res 2001;62: 1500-1506. (Pubitemid 32801950)
43. Rizvi SI, Zaid MA, Anis R, Mishra N: Protective role of tea catechins against oxidation-induced damage of type 2 diabetic erythrocytes. Clin Exp Pharmacol Physiol 2005;32:70-75. (Pubitemid 40314472)
44. Saffari Y, Sadrzadeh SM: Green tea metabolite EGCG protects membranes against oxidative damage in vitro. Life Sci 2004;74: 1513-1518. (Pubitemid 38077213)